EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Olfactory Receptor Activation Reduces Platelet Reactivity and Arterial Thrombosis Through Actin Cytoskeleton Remodeling

Anu Aggarwal iD, Vara Prasad V N Josyula, Nancy Wang iD, Moua Yang, Young Jun Shim iD, Quinn P Kennedy, Reina Samuel, Naseer Sangwan iD, Suman Guntupalli iD, Matthew Godwin iD, Huijun Edelyn Park iD, Mariya Ali und 11 weitere

Circulation · 2026

DOI: 10.1161/circulationaha.125.078927 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, 2026. Verfasst von Anu Aggarwal und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Heart, Blood and Kidney Research, Cleveland Clinic Research, Cleveland Clinic Foundation, OH (A.A., Y.J.S., R.S., N.S., S.G., M.G., H.E…. Hauptthemen laut MEDLINE: Thrombosis, Blood Platelets, Platelet Activation, Receptors, Odorant. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Despite antiplatelet therapy, some patients remain at high ischemic risk because of drug nonresponsiveness or high residual platelet reactivity. We aimed to target an orphan platelet GPCR (G protein–coupled receptor) from the OR (olfactory receptor) family as a novel antithrombotic strategy. METHODS: Using an engineered reporter cell line expressing human OR2L13 , an orphan GPCR implicated in limiting platelet reactivity, we conducted a high-throughput screen of 8000 nonodorant bioactive compounds with counterscreen validation. Subsequent studies assessed platelet function in healthy subjects and patients with coronary artery and peripheral artery disease. Phospho-proteomics revealed key signaling pathways, whereas ex vivo and in vivo studies evaluated the impact of a lead compound on platelet signaling, biomechanics, and thrombosis in both arterial and venous vasculature. RESULTS: We identified 6 OR2L13 (olfactory receptor family 2 subfamily L member 13)-specific agonists that suppressed platelet aggregation and α-granule exocytosis through multiple receptors, suggesting a shared downstream mediator. The lead agonist (CCF0054500) phosphorylated platelet HSP27 (heat shock protein 27), disrupting the actin cytoskeleton and reducing clot retraction (clot area, 70.6 versus 5.2; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombosisBlood PlateletsPlatelet ActivationReceptors, OdorantActin CytoskeletonHumansAnimalsMicePlatelet AggregationHSP27 Heat-Shock ProteinsMolecular ChaperonesMaleFemaleSignal TransductionMice, Inbred C57BLPlatelet Aggregation InhibitorsHeat-Shock Proteins

Stichwörter der Autor:innen

actinsblood plateletsheat-shock proteinsmyocardial infarctionreceptors, odorantthrombosis

Substanzen

Receptors, OdorantHSP27 Heat-Shock ProteinsMolecular ChaperonesHSPB1 protein, humanPlatelet Aggregation InhibitorsHeat-Shock Proteins

Autor:innen und Institutionen

  • Department of Heart, Blood and Kidney Research, Cleveland Clinic Research, Cleveland Clinic Foundation, OH (A.A., Y.J.S., R.S., N.S., S.G., M.G., H.E.P., M.A., C.J., A.R.S., J.D.L., J.G., S.M.S., K.R.M., T.M.M., S.J.C.).
  • Center for Therapeutics Discovery, Cleveland Clinic Research , Cleveland Clinic Foundation, OH (V.P.V.N.J., N.W., S.S.).
  • Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine and Bloodworks Northwest Research Institute, Seattle (M.Y., Q.P.K.).
  • Section of Vascular Medicine, Department of Cardiovascular Medine, Heart Vascular and Thoracic Institute, Cleveland Clinic Foundation, OH (B.R., A. S, S.J.C.).
  • Department of Hematology, Taussig Cancer Center, Cleveland Clinic Foundation, OH (S.J.C.).
  • Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, OH (S.J.C.).

ORCID-Profile: Anu Aggarwal, Nancy Wang, Young Jun Shim, Naseer Sangwan, Suman Guntupalli, Matthew Godwin, Huijun Edelyn Park, Bhairavi Rajasekar, Alliefair Scalise, Anthony R Sloan, Justin D Lathia, Sarah M Schumacher, Keith R McCrae, Thomas M McIntyre, Scott J Cameron

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Aggarwal, A., Josyula, V. P. V. N., Wang, N., Yang, M., Shim, Y. J., Kennedy, Q. P., Samuel, R., Sangwan, N., Guntupalli, S., Godwin, M., Park, H. E., Ali, M., Jennings, C., Rajasekar, B., Scalise, A., Sloan, A. R., Lathia, J. D., Grondolsky, J., Schumacher, S. M., …, & Cameron, S. J. (2026). Olfactory Receptor Activation Reduces Platelet Reactivity and Arterial Thrombosis Through Actin Cytoskeleton Remodeling. Circulation. https://doi.org/10.1161/circulationaha.125.078927

Vancouver

Aggarwal A, Josyula VPVN, Wang N, Yang M, Shim YJ, Kennedy QP, et al. Olfactory Receptor Activation Reduces Platelet Reactivity and Arterial Thrombosis Through Actin Cytoskeleton Remodeling. Circulation. 2026. doi:10.1161/circulationaha.125.078927

BibTeX
@article{Aggarwal2026,
  author = {Aggarwal, Anu and Josyula, Vara Prasad V N and Wang, Nancy and Yang, Moua and Shim, Young Jun and Kennedy, Quinn P and Samuel, Reina and Sangwan, Naseer and Guntupalli, Suman and Godwin, Matthew and Park, Huijun Edelyn and Ali, Mariya and Jennings, Courtney and Rajasekar, Bhairavi and Scalise, Alliefair and Sloan, Anthony R and Lathia, Justin D and Grondolsky, Jessica and Schumacher, Sarah M and Stauffer, Shaun and McCrae, Keith R and McIntyre, Thomas M and Cameron, Scott J},
  title = {Olfactory Receptor Activation Reduces Platelet Reactivity and Arterial Thrombosis Through Actin Cytoskeleton Remodeling},
  journal = {Circulation},
  year = {2026},
  doi = {10.1161/circulationaha.125.078927}
}
Kostenlos starten →